World’s First Platform Combines HD Wireless Ultrasound and Single-Use Handheld Arthroscope on One Tablet

Scheduled for release in early 2023, the new high-definition mi-ultra platform, powered by Clarius, will offer physicians two clear ways to dynamically evaluate the anatomy in diverse care settings. It combines mi-eye 3, the world’s first FDA-cleared single-use 25° arthroscope with Clarius high-definition ultrasound, making them accessible through a single premier tablet. Clarius handheld wireless ultrasound scanners deliver high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost. The new Trice solution will be available with the Clarius L15 HD3, Clarius L20 HD3, L7 HD3 and the C3 HD3 scanners. Clarius is the only ultrasound company with an open software platform that enables easy integration with compatible medical innovations.

“Our partnership with Clarius helps us take our mi-ultra platform to the next level of performance,” said Mark Foster, President and CEO of Trice Medical. “We’re excited about combining our single-use needle scopes with the best handheld ultrasound solution available on one simple, portable tablet. This is the imaging platform of the future, designed to enable therapeutic extremities procedures to be done in cost effective sites of service. Longer orthopedic procedures should be in the main operating rooms, but any procedure that takes longer to turn over the room than it does to complete the procedure is perfect for our platform.”

“We’re delighted that the Trice Medical team has chosen to integrate their ground-breaking arthroscope with Clarius high-definition wireless ultrasound,” added Ohad Arazi, CEO at Clarius Mobile Health. “By combining our efforts, we can bring innovations that deliver better patient care to market sooner.”

Related Links:
Clarius Mobile Health 
Trice Medical